Precision Medicine Insights

Genevera discusses the significance of identifying genomic subgroups in cancer patients, particularly in breast cancer, where successful clustering techniques have led to targeted drug development. However, she highlights the challenges of reproducibility in findings across different cancer types, as varying studies often produce conflicting results regarding subtypes, complicating treatment strategies.